脊柱後弯症治療の世界市場レポート 2025年

脊柱後弯症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.8％で41億米ドルに成長します。予測期間の成長は、個別化治療アプローチ、バイオメカニクス研究の拡大、遠隔モニタリングと遠隔医療サービス、継続的な遺伝子研究に起因しています。予測期間における主な動向には、高度な手術技術、革新的な装具技術、カスタマイズされた治療計画、3Dプリンティングの採用、疼痛管理の革新などがあります。

脊髄損傷の増加は脊柱後弯症治療市場の拡大を促進すると予測されます。脊髄損傷とは、脊椎、椎間板、靭帯、筋肉、神経、その他の支持構造を含む脊椎の構成要素に対するあらゆる損傷、外傷、危害を指します。脊髄損傷による脊柱後弯症の治療には、整形外科的評価、理学療法、装具、手術の可能性、疼痛管理、患者教育と個人に合わせたケアプランに重点を置いた集学的医療チームなど、総合的なアプローチが必要です。例えば、米国の州機関であるアラバマ州公衆衛生局によると、2022年2月、ATRは、2021年の4,734件に対し、2022年には3,817件の頭部および脊髄を含む神経学的損傷を報告しました。その結果、脊髄損傷の増加が脊柱後弯症治療市場の成長に拍車をかけています。

遠隔医療利用の増加は、脊柱後弯症治療市場の成長をさらに促進すると予想されます。遠隔医療とは、テレビ会議、電話、デジタルメッセージングなどの通信技術を通じて遠隔地から提供されるヘルスケアサービスを指します。これにより、患者はヘルスケア施設に出向くことなく、整形外科専門医や脊椎外科医に相談することができ、特に身体的課題を抱える脊柱後弯症患者にとって有益です。例えば、米国を拠点とする非営利団体ロックヘルスは2023年2月、調査回答者の80％が2021年の72％から2022年のある時点で遠隔医療を利用したと報告しました。このように、遠隔医療の利用増加がヘルスケア輸送サービス市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界脊柱後弯症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の脊柱後弯症治療市場：成長率分析
• 世界の脊柱後弯症治療市場の実績：規模と成長, 2019-2024
• 世界の脊柱後弯症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界脊柱後弯症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の脊柱後弯症治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 姿勢性脊柱後弯症
• シューアマン脊柱後弯症
• 先天性脊柱後弯症
• 世界の脊柱後弯症治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 手術と装具
• 世界の脊柱後弯症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来手術センター
• 世界の脊柱後弯症治療市場姿勢性脊柱後弯症の分類、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 思春期の姿勢性脊柱後弯症
• 成人の姿勢性脊柱後弯症
• 世界の脊柱後弯症治療市場、タイプ別のシャイアマン後弯症のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 青年期のショイアマン後弯症
• 成人のシェーアマン脊柱後弯症
• 世界の脊柱後弯症治療市場先天性脊柱後弯症の分類、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タイプI先天性脊柱後弯症
• タイプII先天性脊柱後弯症
• その他の先天性

第7章 地域別・国別分析

• 世界の脊柱後弯症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の脊柱後弯症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脊柱後弯症治療市場：競合情勢
• 脊柱後弯症治療市場：企業プロファイル
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Aspen Medical Products LLC Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Milwaukee Brace Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Zimmer Biomet Holdings Inc.
• Perrigo Company plc
• Teva Pharmaceuticals Inc.
• B. Braun Melsungen Aktiengesellschaft
• Aurobindo Pharma Limited
• Integra LifeSciences Ltd.
• NuVasive Inc.
• DJO Global Inc.
• Globus Medical Inc.
• Boston Orthotics & Prosthetics
• Ossur hf.
• Aesculap Inc.
• DeRoyal Industries Inc.
• MicroPort Scientific Corp.
• Alphatec Holdings Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 脊柱後弯症治療市場2029：新たな機会を提供する国
• 脊柱後弯症治療市場2029：新たな機会を提供するセグメント
• 脊柱後弯症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Kyphoscoliosis is a spinal condition characterized by abnormal forward curvature (kyphosis) and sideways curvature (scoliosis) of the spine, leading to postural and respiratory problems. The treatment involves medical interventions and therapies aimed at managing and correcting the spinal deformity, improving posture, reducing pain, and preventing further spinal curvature.

The main types of kyphoscoliosis include postural kyphosis, Scheuermann's kyphosis, congenital kyphosis, and kyphoscoliosis. Postural kyphosis refers to the rounding or hunching of the back, typically affecting teenagers and young adults. Treatment options for kyphoscoliosis encompass medications, surgery, and bracing, and these are implemented by hospitals, clinics, and ambulatory surgical centers.

The kyphoscoliosis treatment market research report is one of a series of new reports from The Business Research Company that provides kyphoscoliosis treatment market statistics, including kyphoscoliosis treatment industry global market size, regional shares, competitors with a kyphoscoliosis treatment market share, detailed kyphoscoliosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the kyphoscoliosis treatment industry. This kyphoscoliosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The kyphoscoliosis treatment market size has grown strongly in recent years. It will grow from $3.08 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to exploration of regenerative medicine, genetic research contributions, telemedicine and remote monitoring, advancements in rehabilitation programs.

The kyphoscoliosis treatment market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to personalized treatment approaches, expansion of biomechanical research, remote monitoring and telehealth services, continued genetic research. Major trends in the forecast period include advanced surgical techniques, innovative bracing technologies, customized treatment plans, adoption of 3D printing, pain management innovations.

The growing number of spinal cord injuries is anticipated to drive the expansion of the kyphoscoliosis treatment market. Spinal cord injuries refer to any damage, trauma, or harm to the spine's components, including the vertebrae, intervertebral discs, ligaments, muscles, nerves, and other supportive structures, which can lead to the development of kyphoscoliosis and alterations in spinal alignment. Treating kyphoscoliosis caused by spinal cord injuries involves a holistic approach, including orthopedic evaluation, physical therapy, bracing, possible surgery, pain management, and a multidisciplinary healthcare team focused on patient education and personalized care plans. For example, in February 2022, according to the Alabama Department of Public Health, a US-based state agency, the ATR reported 3,817 neurological injuries involving the head and spinal cord in 2022, compared to 4,734 cases in 2021. As a result, the increasing number of spinal cord injuries is fueling the growth of the kyphoscoliosis treatment market.

The rise in telemedicine usage is expected to further drive the growth of the kyphoscoliosis treatment market. Telemedicine refers to healthcare services delivered remotely through telecommunications technologies, such as videoconferencing, phone calls, and digital messaging. It enables patients to consult with orthopedic specialists and spine surgeons without needing to travel to healthcare facilities, which is particularly beneficial for individuals with kyphoscoliosis who may face physical challenges. For example, in February 2023, Rock Health, a US-based non-profit, reported that 80% of survey respondents had used telemedicine at some point in 2022, up from 72% in 2021. Thus, the increased use of telemedicine is contributing to the growth of the healthcare transportation service market.

The increasing incidence of genetic disorders is expected to be a significant catalyst for the growth of the kyphoscoliosis treatment market. Genetic disorders, stemming from abnormalities or mutations in an individual's DNA, often involve spinal curvature abnormalities requiring kyphoscoliosis treatment. The prevalence of genetic conditions in children is estimated to be 1 in 25 in the UK, affecting over 2.4 million individuals. The multidisciplinary treatment approach, encompassing various strategies such as beta-blocker therapy, physical therapy, and orthopedic surgeon supervision, underlines the pivotal role of kyphoscoliosis treatment in managing genetic disorders and contributes to market growth.

Leading companies in the kyphoscoliosis treatment market are developing innovative products, such as the MARVEL Growing Rod System, specifically designed for early-onset scoliosis. The MARVEL Growing Rod System is a posterior stabilizing rod that can be surgically implanted and periodically lengthened through hand-operated mechanical actuation. For example, in July 2023, Globus Medical Inc., a US-based medical device company, launched the MARVEL Growing Rod System. It is designed to assist patients under 10 years old with early-onset scoliosis in achieving and maintaining spinal correction while allowing for continued growth through minimally invasive distraction. The system offers significant distraction, immediate tactile feedback, and automated locking, ensuring reliable growth. This innovative product, the Growing Rod System, is expected to contribute to the future growth of the market.

Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic PLC, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company PLC, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.

North America was the largest region in the kyphoscoliosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the kyphoscoliosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The kyphoscoliosis treatment market consists of revenues earned by entities by providing services such as physical therapy, pain management, specialist psychological support, and medical evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kyphoscoliosis treatment market also includes sales of lumbar support cushions, orthopedic braces, back support belts, and exercise and therapy equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kyphoscoliosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kyphoscoliosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for kyphoscoliosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kyphoscoliosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Postural Kyphosis; Scheuermann's Kyphosis; Congenital Kyphosis
• 2) By Treatment: Medications; Surgery And Bracing
• 3) By End-User: Hospital; Clinics; Ambulatory Surgical Centers
• Subsegments:
• 1) By Postural Kyphosis: Adolescent Postural Kyphosis; Adult Postural Kyphosis
• 2) By Scheuermann's Kyphosis: Adolescent Scheuermann's Kyphosis; Adult Scheuermann's Kyphosis
• 3) By Congenital Kyphosis: Type I Congenital Kyphosis; Type II Congenital Kyphosis; Other Congenital Forms
• Companies Mentioned: Johnson & Johnson Services Inc.; Aspen Medical Products LLC; Medtronic plc; Stryker Corporation; Milwaukee Brace Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Kyphoscoliosis Treatment Market Characteristics

3. Kyphoscoliosis Treatment Market Trends And Strategies

4. Kyphoscoliosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Kyphoscoliosis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Kyphoscoliosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Kyphoscoliosis Treatment Market Growth Rate Analysis
• 5.4. Global Kyphoscoliosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Kyphoscoliosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Kyphoscoliosis Treatment Total Addressable Market (TAM)

6. Kyphoscoliosis Treatment Market Segmentation

• 6.1. Global Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Postural Kyphosis
• Scheuermann's Kyphosis
• Congenital Kyphosis
• 6.2. Global Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Surgery And Bracing
• 6.3. Global Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinics
• Ambulatory Surgical Centers
• 6.4. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Postural Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adolescent Postural Kyphosis
• Adult Postural Kyphosis
• 6.5. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Scheuermann's Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adolescent Scheuermann's Kyphosis
• Adult Scheuermann's Kyphosis
• 6.6. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Congenital Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type I Congenital Kyphosis
• Type II Congenital Kyphosis
• Other Congenital Forms

7. Kyphoscoliosis Treatment Market Regional And Country Analysis

• 7.1. Global Kyphoscoliosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Kyphoscoliosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Kyphoscoliosis Treatment Market

• 8.1. Asia-Pacific Kyphoscoliosis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Kyphoscoliosis Treatment Market

• 9.1. China Kyphoscoliosis Treatment Market Overview
• 9.2. China Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Kyphoscoliosis Treatment Market

• 10.1. India Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Kyphoscoliosis Treatment Market

• 11.1. Japan Kyphoscoliosis Treatment Market Overview
• 11.2. Japan Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Kyphoscoliosis Treatment Market

• 12.1. Australia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Kyphoscoliosis Treatment Market

• 13.1. Indonesia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Kyphoscoliosis Treatment Market

• 14.1. South Korea Kyphoscoliosis Treatment Market Overview
• 14.2. South Korea Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Kyphoscoliosis Treatment Market

• 15.1. Western Europe Kyphoscoliosis Treatment Market Overview
• 15.2. Western Europe Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Kyphoscoliosis Treatment Market

• 16.1. UK Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Kyphoscoliosis Treatment Market

• 17.1. Germany Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Kyphoscoliosis Treatment Market

• 18.1. France Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Kyphoscoliosis Treatment Market

• 19.1. Italy Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Kyphoscoliosis Treatment Market

• 20.1. Spain Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Kyphoscoliosis Treatment Market

• 21.1. Eastern Europe Kyphoscoliosis Treatment Market Overview
• 21.2. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Kyphoscoliosis Treatment Market

• 22.1. Russia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Kyphoscoliosis Treatment Market

• 23.1. North America Kyphoscoliosis Treatment Market Overview
• 23.2. North America Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Kyphoscoliosis Treatment Market

• 24.1. USA Kyphoscoliosis Treatment Market Overview
• 24.2. USA Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Kyphoscoliosis Treatment Market

• 25.1. Canada Kyphoscoliosis Treatment Market Overview
• 25.2. Canada Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Kyphoscoliosis Treatment Market

• 26.1. South America Kyphoscoliosis Treatment Market Overview
• 26.2. South America Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Kyphoscoliosis Treatment Market

• 27.1. Brazil Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Kyphoscoliosis Treatment Market

• 28.1. Middle East Kyphoscoliosis Treatment Market Overview
• 28.2. Middle East Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Kyphoscoliosis Treatment Market

• 29.1. Africa Kyphoscoliosis Treatment Market Overview
• 29.2. Africa Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Kyphoscoliosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Kyphoscoliosis Treatment Market Competitive Landscape
• 30.2. Kyphoscoliosis Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aspen Medical Products LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Milwaukee Brace Company Overview, Products and Services, Strategy and Financial Analysis

31. Kyphoscoliosis Treatment Market Other Major And Innovative Companies

• 31.1. Zimmer Biomet Holdings Inc.
• 31.2. Perrigo Company plc
• 31.3. Teva Pharmaceuticals Inc.
• 31.4. B. Braun Melsungen Aktiengesellschaft
• 31.5. Aurobindo Pharma Limited
• 31.6. Integra LifeSciences Ltd.
• 31.7. NuVasive Inc.
• 31.8. DJO Global Inc.
• 31.9. Globus Medical Inc.
• 31.10. Boston Orthotics & Prosthetics
• 31.11. Ossur hf.
• 31.12. Aesculap Inc.
• 31.13. DeRoyal Industries Inc.
• 31.14. MicroPort Scientific Corp.
• 31.15. Alphatec Holdings Inc.

32. Global Kyphoscoliosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Kyphoscoliosis Treatment Market

34. Recent Developments In The Kyphoscoliosis Treatment Market

35. Kyphoscoliosis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Kyphoscoliosis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Kyphoscoliosis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Kyphoscoliosis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer